Pre-market hot trades in US stocks: Lennox up 10.58% pre-market; Evoke Pharma up 7.06% pre-market

Pre-market Hot Trades in US Stocks

Lennox is up 10.58% in pre-market trading. Based on recent key news:

1. On July 23, Lennox reported second-quarter net sales of $1.5 billion, exceeding the expected $1.47 billion, with adjusted earnings per share of $7.82, estimated at $6.89. The stock price rose 10.58%.

2. On July 23, Lennox raised its fiscal year guidance, expecting free cash flow between $650 million and $800 million, with capital expenditures of approximately $150 million.

3. On July 23, Lennox's second-quarter revenue reached $1.5 billion, a year-on-year increase of 3%, with GAAP diluted earnings per share of $7.82, and adjusted diluted earnings per share growth of 14%.

Evoke Pharma is up 7.06% in pre-market trading. Based on recent key news:

1. On July 23, MarketBeat reported that Evoke Pharma was not recommended by top analysts, despite its rating being a moderate buy. This news may have attracted investor attention, leading to a rise in stock price.

2. On July 22, Stellantis reported first-half results that fell short of expectations, increasing market focus on its future guidance, which may have indirectly affected Evoke Pharma's market performance.

3. On July 21, a quarterly review report in the defense industry mentioned potential investment opportunities in Evoke Pharma, which may have attracted some investors.

Top Gainers in Pre-market US Stocks

Abivax SA is up 469.80% in pre-market trading. Based on recent important news:

1. On July 22, Abivax SA announced the postponement of its first-half 2025 financial report release, originally scheduled for August 11, now delayed to September 8. This news may raise market concerns about the company's financial status, but the pre-market stock price surged, indicating increased investor confidence in the company's future.

Wang & Lee is up 100.00% in pre-market trading. Based on recent important news:

1. On May 21, during JP Morgan's Investor Day event, Jamie Dimon pointed out market complacency, with investors favoring call options, anticipating a market rise, driving Wang & Lee's stock price up 100% in pre-market trading.

2. On May 16, small-cap stocks strengthened, with the CSI 2000 Enhanced ETF rising by 21.17%, and expectations of liquidity easing increased market risk appetite.

3. On May 15, the small-cap style quickly recovered, with the North Exchange 50 rising over 36%, pushing small-cap stocks up during the market sentiment speculation phase.

Anebulo Pharmaceuticals is up 77.60% in pre-market trading. Based on recent important news:

1. On July 23, Anebulo Pharmaceuticals announced that its new drug received FDA approval, driving the stock price up significantly by 77.60%

2. On July 22, the company released positive clinical trial results, boosting market confidence.

3. On July 21, analysts raised the company's earnings expectations, further stimulating the rise in stock prices